Cite
HARVARD Citation
Xue, F. et al. (2015). HERC5 is a prognostic biomarker for post-liver transplant recurrent human hepatocellular carcinoma. Journal of translational medicine. 13 (1), pp. 1-15. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Xue, F. et al. (2015). HERC5 is a prognostic biomarker for post-liver transplant recurrent human hepatocellular carcinoma. Journal of translational medicine. 13 (1), pp. 1-15. [Online].